Jci_page_head_homepage_01 Jci_page_head_homepage_02
Decheng Ren, Yingjiang Zhou, David Morris, Minghua Li, Zhiqin Li, Liangyou Rui
Published in Volume 117, Issue 2
J Clin Invest. 2007; 117(2):397–406 doi:10.1172/JCI29417
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4
Neuron-specific restoration of SH2B1 reverses leptin resistance in SH2B1KO mice.

(A) Plasma leptin levels in fasted (10 weeks old) and fed ad libitum (13 weeks old) mice. (B) Male mice (9 weeks old) were housed individually and injected intraperitoneally with leptin (2 mg/kg body weight) or PBS (control) twice a day (6:00 pm and 12:00 am). Body weight was monitored both before and after the injection. Changes in body weight were calculated as a percentage of the initial values prior to the injection. (C) Female (right panel: 6 weeks old) and male (middle panel: 12 weeks old; right panel: 9 weeks old) mice were fasted for 24 hours and injected intraperitoneally with leptin (1 mg/kg of body weight) or PBS as control. Hypothalamic extracts were prepared 45 minutes after injection and immunoblotted with α–p-STAT3 or α-STAT3. Each lane represents a combination of 2 hypothalami. (D) Hypothalamic RNA was prepared from males (22 weeks old, fasted overnight). NPY, AgRP, and POMC mRNA levels were measured using quantitative real-time PCR and normalized to the expression of β-actin. *P < 0.05.